Therapy for Cytokine Release

About Gb Sciences

Gb Sciences is a Las Vegas-based biopharmaceutical company founded in 2009 with a mission to bridge botanical medicine and modern drug discovery. Its core strategy utilizes the AI-powered PhAROS platform to deconvolute plant mixtures into defined, synergistic drug candidates. The company's key achievement is a patented, cannabinoid-based Parkinson's disease therapy with positive animal proof-of-concept data, now partnered for first-in-human trial sponsorship, alongside a broader preclinical pipeline.

Therapeutic Areas